The human leucocyte antigen-G 14-basepair polymorphism correlates with graft-versus-host disease in unrelated bone marrow transplantation for thalassaemia

被引：44
作者：
La Nasa, Giorgio
Littera, Roberto
Locatelli, Franco
Lai, Sara
Alba, Francesco
Caocci, Giovanni
Lisini, Daniela
Nesci, Sonia
Vacca, Adriana
Piras, Eugenia
Bernardo, Maria Ester
Cesare-Merlone, Alessandra Di
Orru, Sandro
Carcassi, Carlo
机构：
[1] Univ Cagliari, Cattedra Genet Med, Osped R Binaghi, Dipartimento Sci Med Internist, I-09126 Cagliari, Italy
[2] Univ Cagliari, Dipartimento Sci Mediche Internistiche, Osped R Binaghi, Ctr Trapianti Midollo Osseo,Cattedra Ematol, Cagliari, Italy
[3] Osped R Binaghi, Ctr Res Trapianti, Cagliari, Italy
[4] Univ Pavia, Policlin San Matteo, Fonaz IRCCS, I-27100 Pavia, Italy
[5] Osped S Salvatore, Ctr Trapianti Midollo Osseo Muraglia, Unita Operat Ematol, Pesaro, Italy
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2007年 / 139卷 / 02期
关键词：
human leucocyte antigen-G; 14-basepair polymorphism; acute graft-versus-host disease; thalassaemia; bone marrow transplantation;
D O I：
10.1111/j.1365-2141.2007.06779.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The presence of the 14-bp insertion polymorphism of the human leucocyte antigen (HLA)-G gene (HLA-G) promotes immune tolerance through increased synthesis of HLA-G molecules. We investigated this polymorphism in a large cohort of 53 thalassaemia patients transplanted from an unrelated donor. Sixteen patients (30.2%) homozygous for the 14-bp deletion had a higher risk of developing acute graft-versus-host disease (aGvHD) than patients homozygous for the 14-bp insertion (-14-bp/-14-bp vs +14-bp/+14-bp: Relative Risk = 15.0; 95% confidence interval 1.59-141.24; P = 0.008). Therefore, the 14-bp polymorphism could be an important predictive factor for aGvHD following bone marrow transplantation.
引用
收藏
页码：284 / 288
页数：5
相关论文
共 50 条
  • [41] EXPERIMENTAL AND CLINICAL GNOTOBIOTICS - INFLUENCE OF THE MICROFLORA ON GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
    HEIDT, PJ
    VOSSEN, JM
    JOURNAL OF MEDICINE, 1992, 23 (3-4) : 161 - 173
  • [42] Tacrolimus and methotrexate for the prophylaxis of acute graft-versus-host disease in allogeneic bone marrow transplantation in patients with hematologic malignancies
    Uberti, JP
    Silver, SM
    Adams, PT
    Jacobson, P
    Scalzo, A
    Ratanatharathorn, V
    BONE MARROW TRANSPLANTATION, 1997, 19 (12) : 1233 - 1238
  • [43] GRAFT-VERSUS-HOST DISEASE IN BONE-MARROW TRANSPLANTATION - EXPERIMENTAL, LABORATORY, AND CLINICAL CONTRIBUTIONS OF THE LAST FEW YEARS
    KELEMEN, E
    SZEBENI, J
    PETRANYI, GG
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1993, 102 (04) : 309 - 320
  • [44] Bone Marrow Quality Index: A Predictor of Acute Graft-versus-Host Disease in Hematopoietic Stem Cell Transplantation for Thalassemia
    Agarwal, Rajat Kumar
    Dhanya, Rakesh
    Sedai, Amit
    Ankita, Kumari
    Parmar, Lalith
    Ramprakash, Stalin
    Sandeep, Deepa
    Trivedi, Deepa
    Shah, Vaibhav
    Bhat, Neema
    Reddy, Mohan
    Nithya, R.
    Faulkner, Lawrence
    TRANSPLANTATION AND CELLULAR THERAPY, 2023, 29 (11): : 711e1 - 711e6
  • [45] Risk factors for chronic graft-versus-host disease after bone marrow transplantation:: a retrospective single centre analysis
    Carlens, S
    Ringdén, O
    Remberger, M
    Lönnqvist, B
    Hägglund, H
    Klaesson, S
    Mattsson, J
    Svahn, BM
    Winiarski, J
    Ljungman, P
    Aschan, J
    BONE MARROW TRANSPLANTATION, 1998, 22 (08) : 755 - 761
  • [46] Cyclosporin A-induced encephalopathy after allogeneic bone marrow transplantation with prevention of graft-versus-host disease by tacrolimus
    M Takahata
    S Hashino
    K Izumiyama
    K Chiba
    S Suzuki
    M Asaka
    Bone Marrow Transplantation, 2001, 28 : 713 - 715
  • [47] Conjunctival Scrape Cytology Findings in Patients with Chronic Graft-Versus-Host Disease Following Allogeneic Bone Marrow Transplantation
    Hosseini, Hamid
    Kumar, Perikala Vijayananda
    Geramizadeh, Bita
    Nowroozizadeh, Behdokht
    Ramzi, Mani
    ACTA CYTOLOGICA, 2010, 54 (03) : 272 - 276
  • [48] Host MyD88 signaling protects against acute graft-versus-host disease after allogeneic bone marrow transplantation
    Xing, S.
    Zhang, X.
    Liu, J. H.
    Huang, X.
    Zhou, P.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2019, 195 (01) : 121 - 131
  • [49] Bronchiolitis obliterans organizing pneumonia and chronic graft-versus-host disease in a child after allogeneic bone marrow transplantation
    I Kleinau
    A Perez-Canto
    H J Schmid
    A Grassot
    D Staab
    H Renz
    G Henze
    U Wahn
    K Paul
    Bone Marrow Transplantation, 1997, 19 : 841 - 844
  • [50] Risk factors for chronic graft-versus-host disease after bone marrow transplantation: a retrospective single centre analysis
    S Carlens
    O Ringdén
    M Remberger
    B Lönnqvist
    H Hägglund
    S Klaesson
    J Mattsson
    B-M Svahn
    J Winiarski
    P Ljungman
    J Aschan
    Bone Marrow Transplantation, 1998, 22 : 755 - 761
12345